Australia. An analysis of data from the 2011e12 Australian National Health Measures Survey
reported in this issue of the MJA 1 found that most respondents at high risk of cardiovascular …

Twenty years ago an editorial in the Lancet lamented the decision of the United Kingdom
Department of Health to approve the sale in pharmacies of over-the-counter (OTC) …

In women and men, cardiovascular disease is and will remain the leading avoidable cause
of premature death in the United States and is rapidly becoming so worldwide. 1 Although …

Statins, HMG-CoA reductase inhibitors, enhance the expression of low-density lipoprotein
(LDL) receptors in the liver and consequently lower blood LDL cholesterol levels through …

In their mini-review/short communication in this issue of the Archives of Medical Science, Dr.
Paraskevas et al.[1] draw proper attention to the consequences of statin discontinuation …

The 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase inhibitors or statins are the most
successful cardiovascular drugs of all time. By interrupting cholesterol synthesis in the liver …

In May 2004, the British government announced that it was moving forward in developing a
program to provide over-the-counter (OTC) access to a small dose of the 3-hydroxy-3-methyl …

A recent issue of JAMA contains the latest US Preventive Services Task Force (USPSTF)
recommendation statement on statins for prevention of cardiovascular disease in adults, 1 …

Background Statins are the most effective agents currently available for lowering plasma
levels of low-density lipoprotein cholesterol (LDL-C) and are the mainstay of therapy for …

November 2013 in which United States-based commentators criticised the use of statins for
various reasons, including their failure to reduce mortality, inappropriate promotion and …